Your browser doesn't support javascript.
loading
Efficacy of MEK inhibition in patients with histiocytic neoplasms.
Diamond, Eli L; Durham, Benjamin H; Ulaner, Gary A; Drill, Esther; Buthorn, Justin; Ki, Michelle; Bitner, Lillian; Cho, Hana; Young, Robert J; Francis, Jasmine H; Rampal, Raajit; Lacouture, Mario; Brody, Lynn A; Ozkaya, Neval; Dogan, Ahmet; Rosen, Neal; Iasonos, Alexia; Abdel-Wahab, Omar; Hyman, David M.
Afiliación
  • Diamond EL; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Durham BH; Weill Cornell Medical College, New York, NY, USA.
  • Ulaner GA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Drill E; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Buthorn J; Weill Cornell Medical College, New York, NY, USA.
  • Ki M; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bitner L; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cho H; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Young RJ; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Francis JH; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rampal R; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lacouture M; Weill Cornell Medical College, New York, NY, USA.
  • Brody LA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ozkaya N; Ophthalmic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dogan A; Weill Cornell Medical College, New York, NY, USA.
  • Rosen N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Iasonos A; Weill Cornell Medical College, New York, NY, USA.
  • Abdel-Wahab O; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hyman DM; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nature ; 567(7749): 521-524, 2019 03.
Article en En | MEDLINE | ID: mdl-30867592
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Azetidinas / Trastornos Histiocíticos Malignos / Histiocitosis / Quinasas de Proteína Quinasa Activadas por Mitógenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Azetidinas / Trastornos Histiocíticos Malignos / Histiocitosis / Quinasas de Proteína Quinasa Activadas por Mitógenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido